Trial intelligence / Profile preview

Inhaled Tranexamic Acid in Pediatric Pulmonary Hemorrhage

NCT07481682Completed

Sponsor
Tanta University
Start
Aug 2023
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Trial of tranexamic acid in pulmonary hemorrhage (2 arms), sponsored by Tanta University. Primary endpoints: Cessation of pulmonary hemorrhage at 48 hours and Incidence of adverse effects at 48 hours. Started Aug 2023; status: completed.

02

Drugs

tranexamic acid
03

Conditions

pulmonary hemorrhage

Beyond the preview

Go deeper on NCT07481682.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07481682.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call